Access to medicines after TRIPS: Is compulsory licensing an effective mechanism to lower drug prices? A review of the existing evidence

Eduardo Urias*, Shyama V. Ramani

*Corresponding author for this work

Research output: Contribution to journal › (Systematic) Review article › peer-review

Fingerprint

Dive into the research topics of 'Access to medicines after TRIPS: Is compulsory licensing an effective mechanism to lower drug prices? A review of the existing evidence'. Together they form a unique fingerprint.

INIS

Keyphrases

Social Sciences

Economics, Econometrics and Finance